GGV Logo GGV Logo

Department of Pharmacy

Guru Ghasidas Vishwavidyalaya, Bilaspur | School of Studies of Natural Resources

Dr. Sanjay Kumar Bharti

  • Associate Professor
  • sanjay.itbhu@gmail.com
  • 9301808566

Personal Information

  • Full Name: Dr. Sanjay Kumar Bharti
  • Mobile Number: 9301808566
  • EmailID: sanjay.itbhu@gmail.com
  • Designation: Associate Professor
Qualification

  • 2011
    Ph. D.

    IIT(BHU)-Varanasi

  • 2006
    M. Pharm.

    RGPV, Bhopal

  • 2003
    B. Pharm.

    IIT(BHU)-Varanasi

Experience

  • 2024 - 2025
    Associate Professor

    Guru Ghasidas Vishwavidyalaya (A Central University)

  • 2012 - 2024
    Assistant Professor

    Guru Ghasidas Vishwavidyalaya (A Central University)

  • 2010 - 2012
    Lecturer

    National Institute of Pharmaceutical Education and Research (NIPER), Hajipur

Doctoral Theses Guided

Design, synthesis and biological evaluation of newer thiazolidine-2,4-diones as anticancer agents

  • Guru Ghasidas Vishwavidyalaya (A Central University)

  • Mr. Vivek Asati

Research Projects

Design and synthesis of some novel metal (Co, Ni, Ga) complexes of bi-/tridentate ligand(s) as potential nucleolytic and anticancer agents

Completed Amount: ₹6.00

Funding Agency: UGC, New Delhi

Duration : 01:04:2013 - 31:03:2015

Publications

An updated patent review on rational combinations of HDAC inhibitors for cancer chemotherapy (2020 – present): part 1-patent granted

Yugal Kishor Shukla, Vandana, Vivekananda Mandal, Vivek Asati, Raj K. Keservani, Sanjay Kumar Bharti

Publication Type: Journal Article (International)

Journal: Expert Opinion on Therapeutic Patents

Year: 2025

DOI: https://doi.org/10.1080/13543776.2025.2546595

Impact Factor: 5.40

An updated patent review on rational combinations of HDAC inhibitors for cancer chemotherapy (2020 – present): part 2 - patent published

Yugal Kishor Shukla, Vandana, Vivekananda Mandal, Vivek Asati, Raj K. Keservani, Sanjay Kumar Bharti

Publication Type: Journal Article (International)

Journal: Expert Opinion on Therapeutic Patents

Volume: 35(8)

Year: 2025

Pages: 875–900

Impact Factor: 5.40

logo